AnalystsSwayampakula RamakanthSwayampakula Ramakanth's Stock Forecasts
AnalystsSwayampakula Ramakanth
Analyst Ranking
Bottom 1%
#4849 out of 4868 analysts
Average Return
-5.52%
Win Rate
33%169 out of 513
Risk vs Reward
Poor
Good
Swayampakula Ramakanth's 5 best and worst ratings
| Name / Ticker | Gain/Loss | Entry Price | Exit Price | Period | Rating |
|---|---|---|---|---|---|
Janux Therapeutics IncJANX | +645.28% | $7.09 | $52.84 | 2023-11-12 - 2024-11-12 | Buy |
Immunogen IncIMGN | +559.55% | $4.45 | $29.35 | 2023-03-01 - 2023-11-30 | Buy |
Immunogen IncIMGN | +491.73% | $4.96 | $29.35 | 2022-12-29 - 2023-11-30 | Buy |
Immunogen IncIMGN | +432.67% | $5.51 | $29.35 | 2023-04-30 - 2023-11-30 | Buy |
Electrocore IncECOR | +362.22% | $6.75 | $31.20 | 2020-03-23 - 2021-03-24 | Buy |
Swayampakula Ramakanth Analyst Color
Get additional color on Swayampakula Ramakanth's coverage of popular stocks
Swayampakula Ramakanth's Stock Coverage
| Name / Ticker | No. Ratings | Rating | Price Target | Upside/Downside | Action | Date |
|---|---|---|---|---|---|---|
Innate Pharma SaIPHA | 15 | Buy | $11.00 | +393.27% | Reiterates | 7 days ago |
Immunoprecise Antibodies LtdIPA | 11 | Buy | $5.00 | +1,041.55% | Reiterates | 20 days ago |
Renovorx IncRNXT | 2 | Buy | $3.00 | +212.50% | Reiterates | a month ago |
Evaxion Biotech AEVAX | 12 | Buy | $14.00 | +815.03% | Reiterates | a month ago |
Spectral Ai IncMDAI | 4 | Buy | $3.50 | +169.23% | Reiterates | a month ago |
Celcuity IncCELC | 6 | Buy | $27.00 | +142.37% | Reiterates | a month ago |
Corcept Therapeutics IncCORT | 19 | Buy | $150.00 | +108.68% | Maintains | a month ago |
Edap Tms SaEDAP | 12 | Buy | $19.00 | +796.23% | Reiterates | a month ago |
X4 Pharmaceuticals IncXFOR | 15 | Buy | $45.00 | +944.08% | Reiterates | a month ago |
Vor Biopharma IncVOR | 11 | Buy | $13.00 | +1,814.58% | Maintains | a month ago |
Elevation Oncology IncELEV | 8 | Buy | $1.00 | +168.82% | Maintains | a month ago |
Mediwound LtdMDWD | 17 | Buy | $25.00 | +41.20% | Reiterates | a month ago |
Precigen IncPGEN | 10 | Buy | $6.00 | +284.62% | Reiterates | a month ago |
Absci CorpABSI | 14 | Buy | $7.00 | +128.01% | Reiterates | a month ago |
Pyxis Oncology IncPYXS | 8 | Buy | $5.00 | +354.55% | Reiterates | a month ago |
Eton Pharmaceuticals IncETON | 7 | Buy | $33.00 | +95.85% | Reiterates | a month ago |
Actuate Therapeutics IncACTU | 1 | Buy | $20.00 | +117.39% | Initiates Coverage On | a month ago |
In8bio IncINAB | 15 | Buy | $6.00 | +3,450.30% | Maintains | 2 months ago |
Electrocore IncECOR | 13 | Buy | $25.00 | +239.90% | Reiterates | 2 months ago |
Dianthus Therapeutics IncDNTH | 5 | Buy | $40.00 | +83.07% | Reiterates | 2 months ago |
Lifeward LtdLFWD | 16 | Buy | $13.00 | +821.99% | Reiterates | 2 months ago |
Delcath Systems IncDCTH | 12 | Buy | $24.00 | +99.34% | Maintains | 2 months ago |
Alx Oncology Holdings IncALXO | 14 | Buy | $5.00 | +825.93% | Reiterates | 2 months ago |
Ocugen IncOCGN | 18 | Buy | $8.00 | +970.95% | Reiterates | 2 months ago |
Iteos Therapeutics IncITOS | 11 | Buy | $46.00 | +534.48% | Reiterates | 2 months ago |
Ekso Bionics Holdings IncEKSO | 11 | Buy | $9.00 | +1,798.73% | Reiterates | 2 months ago |
Janux Therapeutics IncJANX | 12 | Buy | $70.00 | +110.84% | Reiterates | 2 months ago |
Nuvalent IncNUVL | 3 | Buy | $110.00 | +43.32% | Reiterates | 2 months ago |
Personalis IncPSNL | 14 | Buy | $8.00 | +111.64% | Reiterates | 2 months ago |
Vericel CorpVCEL | 15 | Buy | $60.00 | +57.81% | Reiterates | 2 months ago |
Bicycle Therapeutics PLCBCYC | 16 | Buy | $33.00 | +285.51% | Reiterates | 2 months ago |
Leap Therapeutics IncLPTX | 13 | Buy | $5.50 | +1,215.79% | Reiterates | 3 months ago |
Quantum Si IncQSI | 6 | Buy | $5.50 | +382.46% | Reiterates | 4 months ago |
Affimed NvAFMD | 12 | Buy | $10.00 | +905.03% | Reiterates | 5 months ago |
Collplant Biotechnologies LtdCLGN | 9 | Buy | $11.00 | +418.87% | Reiterates | 5 months ago |
Intensity Therapeutics IncINTS | 2 | Buy | $5.00 | +750.34% | Reiterates | 5 months ago |
Cyclo Therapeutics IncCYTH | 4 | Hold | $0.95 | +31.76% | Downgrades | 8 months ago |
Predictive Oncology IncPOAI | 1 | Buy | $3.00 | +172.73% | Initiates Coverage On | 8 months ago |
Asensus Surgical IncASXC | 11 | Hold | $0.35 | +0.57% | Reiterates | a year ago |
Mimedx Group IncMDXG | 8 | Buy | $11.00 | +59.88% | Reiterates | a year ago |
Calcimedica IncCALC | 1 | Buy | $20.00 | N/A | Reiterates | a year ago |
Avinger IncAVGR | 5 | Buy | $5.00 | N/A | Reiterates | a year ago |
Harpoon Therapeutics IncHARP | 8 | Hold | $23.00 | N/A | Downgrades | a year ago |
Solid Biosciences IncSLDB | 1 | Buy | $9.00 | N/A | Initiates Coverage On | a year ago |
Immunogen IncIMGN | 10 | Hold | $31.26 | N/A | Downgrades | a year ago |
Medicenna Therapeutics CorpMDNAF | 9 | Buy | $2.50 | N/A | Reiterates | 2 years ago |
Surface Oncology IncSURF | 6 | Hold | $5.00 | N/A | Downgrades | 2 years ago |
Alaunos Therapeutics IncTCRT | 3 | Buy | $225.00 | N/A | Upgrades | 2 years ago |
Surgalign Holdings IncSRGAQ | 3 | Buy | $3.50 | N/A | Reiterates | 2 years ago |
Codexis IncCDXS | 9 | Buy | $9.00 | N/A | Maintains | 2 years ago |
Lava Therapeutics NvLVTX | 1 | Buy | $9.00 | N/A | Reiterates | 2 years ago |
Celularity IncCELU | 2 | Buy | $25.00 | N/A | Maintains | 2 years ago |
Poseida Therapeutics IncPSTX | 1 | Buy | $15.00 | N/A | Initiates Coverage On | 2 years ago |
Adagene IncADAG | 1 | Buy | $5.00 | N/A | Initiates Coverage On | 2 years ago |
Oncorus IncONCR | 2 | Hold | N/A | N/A | Downgrades | 2 years ago |
Cellectar Biosciences IncCLRB | 1 | Buy | $4.00 | N/A | Maintains | 2 years ago |
Aveo Pharmaceuticals IncAVEO | 4 | Hold | $15.00 | N/A | Downgrades | 3 years ago |
Calithera Biosciences IncCALA | 2 | Buy | $8.00 | N/A | Upgrades | 3 years ago |
Cervomed IncCRVO | 3 | Buy | $9.50 | N/A | Upgrades | 3 years ago |
Bioatla IncBCAB | 2 | Buy | $20.00 | N/A | Maintains | 3 years ago |
Jounce Therapeutics IncJNCE | 1 | Buy | $11.00 | N/A | Maintains | 3 years ago |
Notable Labs LtdNTBLQ | 4 | Hold | N/A | N/A | Downgrades | 3 years ago |
Pulse Biosciences IncPLSE | 5 | Hold | N/A | N/A | Downgrades | 3 years ago |
Hookipa Pharma IncHOOK | 5 | Buy | $80.00 | N/A | Maintains | 3 years ago |
Trillium Therapeutics IncTRIL | 3 | Hold | $18.50 | N/A | Downgrades | 4 years ago |
Carisma Therapeutics IncCARM | 2 | Hold | N/A | N/A | Downgrades | 4 years ago |
Corvus Pharmaceuticals IncCRVS | 3 | Buy | $6.00 | N/A | Maintains | 4 years ago |
Kindred Biosciences IncKIN | 3 | Hold | $9.25 | N/A | Downgrades | 4 years ago |
Perspective Therapeutics IncCATX | 2 | Buy | $2.10 | N/A | Maintains | 4 years ago |
Inmune Bio IncINMB | 2 | Buy | $20.00 | N/A | Maintains | 5 years ago |
Intelgenx Technologies CorpIGXT | 1 | Buy | $0.50 | N/A | Reiterates | 5 years ago |
Casi Pharmaceuticals IncCASI | 1 | Buy | $35.00 | N/A | Maintains | 5 years ago |
Verastem IncVSTM | 1 | Buy | $33.00 | N/A | Maintains | 5 years ago |
Alphatec Holdings IncATEC | 2 | Buy | $9.50 | N/A | Reiterates | 5 years ago |
Redhill Biopharma LtdRDHL | 1 | Buy | $14,000.00 | N/A | Reiterates | 5 years ago |
Forty Seven IncFTSV | 1 | Hold | $95.50 | N/A | Downgrades | 5 years ago |
Correvio Pharma CorpCORV | 1 | Hold | N/A | N/A | Downgrades | 5 years ago |
Ayala Pharmaceuticals IncADXS | 2 | Buy | $7,200.00 | N/A | Maintains | 7 years ago |
Aratana Therapeutics IncPETX | 1 | Buy | $10.00 | N/A | Initiates Coverage On | 7 years ago |
Aceragen IncACGN | 1 | Buy | $4.00 | N/A | Initiates Coverage On | 7 years ago |
Spectrum Pharmaceuticals IncSPPI | 1 | Buy | $14.00 | N/A | Assumes | 8 years ago |
Seaspine Holdings CorpSPNE | 1 | Buy | $15.00 | N/A | Initiates Coverage On | 8 years ago |
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletterWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.